General Pharma Flashcards

1
Q

refers to the amount of a drug that reaches the systemic circulation

A

bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

used to determine the safety and efficacy of generic drug

A

bioequivalence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

measures the dose or concentration required to bring about 50% of the drug’s maximal effect

A

potency/ EC50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

dose at which 50% of the individuals exhibit the specified quantal effect

A

ED50/ median effective dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

dose at which 50% of the animals manifest a particular toxic effect

A

TD50/ median toxic dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

transfer of drug from site of administration to bloodstream

A

absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

refers the apparent volume into which the drug is able to distribute

A

volume of distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

elimination of drug at a constant rate

A

zero order kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

elimination at a rate that is proportional to the serum concentration of the drug

A

first order kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

addition of a polar moiety (sulfate, acetate or glucuronate)

A

phase II metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

use of CYP 450 system oxidation, reduction or hydrolysis

A

phase I metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describes the rate at which a specific drug is cleared from the system

A

clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

refers to the amount of time required for the amount of the drug in the body to decrease to half of its value after the administration of the drug has been stopped

A

half life ( t 1/2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

defined as the single amount of drug that is needed achieve a desired plasma concentration quickly

A

loading dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

amount of drug that must be given over time to maintain desired plasma concentration

A

maintenance dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

used as a measure of drugs safety

A

therapeutic index

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

formula for therapeutic index

A

TD50/ED50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

refers to the dosage range between the minimum effective therapeutic concentration or dose and minimum toxic concentration or dose

A

therapeutic window

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

substance that shifts the graded dose-response curve to the right

A

competitive antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

substance that does not produce the same maximum effect and is exhibited by a decrease in the Emax

A

partial antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

substance that depress the graded-dose response curve

A

noncompetitive antagonist

22
Q

an antagonist that interacts directly with the agonist and not at all or only incidentally with the receptor

A

chemical antagonist

23
Q

the action of the drug on the body

A

pharmacodynamics

24
Q

the action of the body on the drug

A

pharmacokinetics

25
permeation that is governed by Fick's Law
liquid diffusion aqueous diffusion
26
permeation that is saturable and inhibitable
carrier-mediated transport
27
adverse effect that is infrequently observed in most patients
idiosyncratic reactions
28
responsiveness diminishes rapidly after drug administration
tachyphylaxis
29
induction of developmental defects in the fetus
teratogenesis
30
induction of malignant characteristics in cells
carcinogenesis
31
induction of changes in the genetic material of animals of any age
mutagenesis
32
Cytochrome P450 INDUCERS
[Ethel Booba takes Phen-Phen and Refuses Greasy Carb Shakes] Ethanol (chronic ingestion) Barbiturates exc. Secobarbital - an inhibiot Phenytoin Rifampicin Griseofulvin Carbamazepine St. John's Work / Smoking Others: Glytethimide, Phenylbutazone (induces the metabolism of Aminopyrine, Cortisol, Digitoxin), Ritonavir
33
Cytochrome P450 INHIBITORS
``` [Inhibitors Stop Cyber Kids from Eating GRApefruit QV] Isoniazid Sulfonamides Cimetidine Ketoconazole Erythromycin Grapefruit Juice Ritonavir (on acute ingestion) Amiodarone Quinidine Valproic Acid Others: Allopurinol, Chloramphenicol, Chlopromazine, Dicumarol, Disulfiram, Ethanol (acute toxicity), Itraconazole, Nortriptyline, oral contraceptives, Phenylbutazone (inhibits the metabolism of phenytoin and tolbutamide), Saquinavir, Secobarbital, Spironolactone, Troleandromycin ```
34
Narrow Therapeutic Index Drugs
``` [WALA na Cyang PaPa! VasTeD na! Warfarin Aminoglycosides Lithium Amphotericin B Carbamazepine Phenobarbital Phenytoin Vancomycin Theophylline Digoxin ```
35
Zero Order Kinetics Drugs
``` [WHAT PET] Warfarin Heparin Aspirin Tolbutamide Phenytoin Ethanol Theophylline ```
36
Drugs that cause Tachyphylaxis
``` [MED students Love to watch CNN in HD] Metoclopramide Ephedrine Dobutamine LSD Calcitonin Nitroglycerin Nicotin Hydralazine Desmopressin ```
37
Route of Drug Administration: 100% bioavailability
Intravenous
38
Route of Drug Administration: first pass effect
Oral
39
Route of Drug Administration: Partial avoidance of first pass effect
Rectal, SL
40
Route of Drug Administration: application to skin for local effect
Topical
41
Route of Drug Administration: Application to skin for systemic effect
Transdermal
42
Phase of drug studies with small number of normal volunteers
phase I
43
Phase of drug studies with post-marketing surveillance
phase IV
44
Phase of drug studies: "does it work in patients?"
phase II
45
Phase of drug studies with randomized, double-blind, controlled trials
phase III
46
a drug for rare disease
orphan drug
47
Volume of distribution formula
Vd= dose/TC
48
Steady state concentration (Css) formula
Css= infusion rate/clearance
49
vasoCONSTRICTors
``` “AVENU” Angiotensin II Vasopressin Endothelin Neuropeptide Y Uropeptides ```
50
vasoDILATors
``` “KVSCANN” Kinins VIP Substance P CGRP Adrenomedullin Natriuretic Peptide Neurotensin ```
51
Acetylcholinesterase inhibitors
Neostigmine, Pyridostigmine -myasthenia gravis Physostigmine -glaucoma Donepezil, rivastigmine, galantamine -Alzheimer disease